Home/Products /levosalbutamol-1-point-25mg-ipratropium-500mcg-respule

Levosalbutamol + Budesonide in pharma franchise in Sikkim

Name: Levosalbutamol (1.25mg) + Ipratropium (500mcg) – Critsal 1.25 Respule
Brand: Critsal 1.25 Respule
Rating: 4.8 (150 reviews)

Levosalbutamol + Budesonide in PCD pharma franchise in Amaravati

Levosalbutamol + Budesonide in top pharma company in Bhubaneswar

Levosalbutamol + Budesonide in pcd pharma supplier in Udupi

Levosalbutamol + Budesonide in phama franchise company in India

Levosalbutamol + Budesonide in phama distributor in Bharuch

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Stimulant

Urology

Levosalbutamol + Ipratropium at the best price in PCD Pharma Franchise for Bronchodilator and Asthma and COPD Management.

Levosalbutamol + Ipratropium at the best price in Third Party Manufacturing for Bronchodilator and Asthma and COPD Management.

Levosalbutamol + Ipratropium at the best price in Third Party Pharma Export in Navi Mumbai for Bronchodilator and Asthma and COPD Management.

Levosalbutamol + Ipratropium at the best price in Top Pharma Company for Bronchodilator and Asthma and COPD Management.

Critsal 1.25 Respule at the best price in Respiratory pharma Franchise.

Critsal 1.25 Respule

Composition : Levosalbutamol (1.25mg) + Ipratropium (500mcg)

Dosage Form : Respule

Packaging Type : Sachets

Packaging : 4*5*2ml

Price : ₹215/-

Please Contact For Best Price

Critsal 1.25 Respule is a combination of two active ingredients, Levosalbutamol (1.25mg) and Ipratropium (500mcg), designed to provide relief from respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Levosalbutamol is a selective beta-2 agonist that works by relaxing the muscles in the airways, making breathing easier. Ipratropium, an anticholinergic agent, helps to further open the airways by inhibiting the effects of acetylcholine, which constricts the bronchial muscles.

This dual-action formula makes Critsal 1.25 Respule particularly effective for individuals with bronchospasm, wheezing, and shortness of breath. By combining the bronchodilator effects of Levosalbutamol with the anticholinergic action of Ipratropium, this medication provides both immediate and sustained relief from acute symptoms of asthma and COPD, helping to improve lung function and reduce exacerbations.

Critsal 1.25 Respule is administered via a nebulizer, ensuring fast and efficient delivery of the medication directly to the lungs. It is commonly used in emergency settings or for patients who are unable to use inhalers effectively. This treatment option is beneficial for individuals who require rapid bronchodilation to ease breathing difficulties.